A significant shift in our drug policy has occurred, as the regulators allow the legalization of psilocybin fungi for therapeutic applications. Previously, these substances were strictly restricted, but a increasing body of evidence suggests they potentially offer benefits for mental health conditions like PTSD. The new policy represents a key step